| Nome |
# |
|
Diagnostic and therapeutic approach to the ACS patient, file e4233f19-63ef-2860-e053-6605fe0a460a
|
82
|
|
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation, file e4233f17-ddc0-2860-e053-6605fe0a460a
|
47
|
|
A highly-detailed anatomical study of normal pericardial structures as revealed by in-vivo computed tomography and magnetic resonance images and ex-vivo novel 3D reconstructions from Visible Human Server, file e4233f18-8572-2860-e053-6605fe0a460a
|
40
|
|
Thromboembolic and bleeding risk in obese patients with atrial fibrillation according to different anticoagulation strategies, file e4233f17-a8a0-2860-e053-6605fe0a460a
|
27
|
|
Early Subclinical Atherosclerosis in Gestational Diabetes: The Predictive Role of Routine Biomarkers and Nutrigenetic Variants, file e4233f17-033b-2860-e053-6605fe0a460a
|
24
|
|
The acute impact of high-dose lipid-lowering treatment on endothelial progenitor cells in patients with coronary artery disease-The REMEDY-EPC early substudy, file e4233f16-0bf9-2860-e053-6605fe0a460a
|
23
|
|
Intraventricular flow patterns during right ventricular apical pacing, file e4233f17-453e-2860-e053-6605fe0a460a
|
23
|
|
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs, file e4233f17-e195-2860-e053-6605fe0a460a
|
23
|
|
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway, file e4233f17-720f-2860-e053-6605fe0a460a
|
22
|
|
Isolated Exercise-Induced Pulmonary Hypertension Associates with Higher Cardiovascular Risk in Scleroderma Patients, file e4233f17-affe-2860-e053-6605fe0a460a
|
22
|
|
Prognostic value of pulmonary blood volume by first-pass contrast-enhanced CMR in heart failure outpatients: The PROVE-HF study, file e4233f17-86b5-2860-e053-6605fe0a460a
|
21
|
|
Clustering of blood cell count abnormalities and future risk of death, file e4233f18-8ca9-2860-e053-6605fe0a460a
|
21
|
|
Left Atrial Remodeling and Stroke in Patients With Sinus Rhythm and Normal Ejection Fraction: ARIC-NCS, file e4233f19-19b6-2860-e053-6605fe0a460a
|
20
|
|
Late Thrombosis After Double Versus Single Drug-Eluting Stent in the Treatment of Coronary Bifurcations : a meta-analysis of randomized and observational Studies., file e4233f15-d565-2860-e053-6605fe0a460a
|
14
|
|
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering, file e4233f18-df6e-2860-e053-6605fe0a460a
|
13
|
|
Transcriptome-based identification of new anti-anti-inflammatory and vasodilating properties of the n-3 fatty acid docosahexaenoic acid in vascular endothelial cell under proinflammatory conditions, file e4233f15-42b3-2860-e053-6605fe0a460a
|
12
|
|
Inconsistency of different methods for assessing ex vivo platelet function: relevance for the detection of aspirin resistance, file e4233f15-c328-2860-e053-6605fe0a460a
|
12
|
|
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study, file e4233f18-79bb-2860-e053-6605fe0a460a
|
11
|
|
Mortality Prediction of the CHA2DS2-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation, file e4233f18-3cbf-2860-e053-6605fe0a460a
|
10
|
|
High-sensitivity troponin I with or without ultra-sensitive copeptin for the instant rule-out of acute myocardial infarction, file 3e25453b-4c36-4b82-9a01-f5e5ad55e45c
|
9
|
|
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies, file e4233f18-df6a-2860-e053-6605fe0a460a
|
9
|
|
Correction: Transcriptome-Based Identification of New Anti-Anti-Inflammatory and Vasodilating Properties of the n-3 Fatty Acid Docosahexaenoic Acid in Vascular Endothelial Cell Under Proinflammatory Conditions, file be6c193d-b2b7-484b-af8f-9d2806ff0954
|
8
|
|
Response to "Pharmacodynamic Interaction Between Aspirin and Ibuprofen: A Plausible Mechanism of Aspirin Resistance", file e4233f15-bc43-2860-e053-6605fe0a460a
|
7
|
|
Increased left atrial size in obese children and its association with insulin resistance: a pilot study, file e4233f15-bf32-2860-e053-6605fe0a460a
|
7
|
|
Concentric remodeling detection by magnetocardiography in patients with recent onset arterial hypertension, file e4233f15-015d-2860-e053-6605fe0a460a
|
5
|
|
Empagliflozin inhibits excessive autophagy through the AMPK/GSK3β signaling pathway in diabetic cardiomyopathy, file ccf7bd56-6576-4a4e-b0bd-7295b3191d69
|
4
|
|
Non-Invasive In Vivo Detection of Peripheral Limb Ischemia Improvement in the Rat After Adipose Tissue-Derived Stromal Cell Transplantation, file e4233f15-a088-2860-e053-6605fe0a460a
|
4
|
|
Right heart-pulmonary circulation unit and cardiac resynchronization therapy, file e4233f16-4dba-2860-e053-6605fe0a460a
|
4
|
|
From short-term blood pressure variability to atherosclerosis: Relative roles of vascular stiffness and endothelial dysfunction, file e4233f17-e2f6-2860-e053-6605fe0a460a
|
4
|
|
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study, file e4233f18-a9fb-2860-e053-6605fe0a460a
|
4
|
|
Ex Vivo Antiplatelet Effects of Oral Anticoagulants, file 39a3d27b-9e50-4478-9063-e6c71da744e7
|
3
|
|
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease, file e4233f14-f17c-2860-e053-6605fe0a460a
|
3
|
|
Triple antithrombotic therapy with aspirin, clopidogrel and warfarin – a persisting dilemma, file e4233f14-ff20-2860-e053-6605fe0a460a
|
3
|
|
The left atrial appendage: from embryology to prevention of thromboembolism, file e4233f15-9587-2860-e053-6605fe0a460a
|
3
|
|
Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects, file e4233f15-c32d-2860-e053-6605fe0a460a
|
3
|
|
Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension, file e4233f15-c52e-2860-e053-6605fe0a460a
|
3
|
|
AF: current and forthcoming antithrombotic therapies, file e4233f15-cc29-2860-e053-6605fe0a460a
|
3
|
|
Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillation ∗, file e4233f17-719c-2860-e053-6605fe0a460a
|
3
|
|
Reduction of atherothrombotic burden before stent deployment in non-ST elevation acute coronary syndromes: Reduction of myocardial necrosis achieved with nose-dive manual thrombus aspiration (REMNANT) trial. A volumetric intravascular ultrasound study, file e4233f17-86cd-2860-e053-6605fe0a460a
|
3
|
|
Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin, file e4233f17-e456-2860-e053-6605fe0a460a
|
3
|
|
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors, file e4233f14-f8cf-2860-e053-6605fe0a460a
|
2
|
|
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper, file e4233f15-a88d-2860-e053-6605fe0a460a
|
2
|
|
Non-vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation - An Updated Meta-analysis, file e4233f15-adbf-2860-e053-6605fe0a460a
|
2
|
|
Late coronary thrombosis after drug-eluting stent: stent vs patient-driven prescription of aspirin-clopidogrel combination, file e4233f15-bb6e-2860-e053-6605fe0a460a
|
2
|
|
Dabigatran as an alternative to warfarin for the prevention of thromboembolism in atrial fibrillation, file e4233f15-bfa4-2860-e053-6605fe0a460a
|
2
|
|
Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials, file e4233f15-c1c1-2860-e053-6605fe0a460a
|
2
|
|
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W, file e4233f15-c32a-2860-e053-6605fe0a460a
|
2
|
|
Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions, file e4233f15-c37e-2860-e053-6605fe0a460a
|
2
|
|
Facilitated PCI: Rationale, current evidence, open questions and future directions, file e4233f15-c385-2860-e053-6605fe0a460a
|
2
|
|
The new oral anticoagulants in atrial fibrillation: Once daily or twice daily?, file e4233f15-c443-2860-e053-6605fe0a460a
|
2
|
|
Genetic determinants of blood pressure responses to caffeine drinking, file e4233f15-c450-2860-e053-6605fe0a460a
|
2
|
|
Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents, file e4233f15-c4c4-2860-e053-6605fe0a460a
|
2
|
|
Measurements of thromboxane production and their clinical significance in coronary heart disease, file e4233f15-c532-2860-e053-6605fe0a460a
|
2
|
|
New anticoagulants for atrial fibrillation, file e4233f15-c631-2860-e053-6605fe0a460a
|
2
|
|
Impact of antiplatelet therapy in heart disease, file e4233f15-c7cf-2860-e053-6605fe0a460a
|
2
|
|
Tumori cardiaci: Il ruolo della risonanza magnetica, file e4233f16-4091-2860-e053-6605fe0a460a
|
2
|
|
Proteomic profiling of coronary thrombus in acute myocardial infarction, file e4233f16-f424-2860-e053-6605fe0a460a
|
2
|
|
Intraoperative ischemia and long-term events after minimally invasive coronary surgery, file e4233f17-6e03-2860-e053-6605fe0a460a
|
2
|
|
Role and importance of ultrasound lung comets in acute cardiac care, file e4233f17-6ef7-2860-e053-6605fe0a460a
|
2
|
|
Effect of high-dose atorvastatin reload on the release of endothelial progenitor cells in patients on long-term statin treatment who underwent percutaneous coronary intervention (from the ARMYDA-EPC Study), file e4233f17-7a62-2860-e053-6605fe0a460a
|
2
|
|
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy, file e4233f17-7b1c-2860-e053-6605fe0a460a
|
2
|
|
Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score, file e4233f17-cd95-2860-e053-6605fe0a460a
|
2
|
|
La gestione del rischio tromboembolico nei pazienti con fibrillazione atriale in Italia: Dati al follow-up del Registro Europeo PREFER in AF, file e4233f17-e132-2860-e053-6605fe0a460a
|
2
|
|
Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries, file e4233f17-e198-2860-e053-6605fe0a460a
|
2
|
|
Does optical coherence tomography identify arterial healing after stenting? An in vivo comparison with histology, in a rabbit carotid model, file e4233f14-ef96-2860-e053-6605fe0a460a
|
1
|
|
Transplantation of Mesenchymal Cells Improves Peripheral Limb Ischemia in Diabetic Rats, file e4233f15-abd3-2860-e053-6605fe0a460a
|
1
|
|
Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe., file e4233f15-bd64-2860-e053-6605fe0a460a
|
1
|
|
Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry, file e4233f15-bf2a-2860-e053-6605fe0a460a
|
1
|
|
Coffee and Hypertension: A Focus on Contrasting Acute and Chronic Effects and Nutrigenetics, file e4233f15-c334-2860-e053-6605fe0a460a
|
1
|
|
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial, file e4233f15-c43d-2860-e053-6605fe0a460a
|
1
|
|
Increased short-term blood pressure variability is associated with early left ventricular systolic dysfunction in newly diagnosed untreated hypertensive patients., file e4233f15-c4b6-2860-e053-6605fe0a460a
|
1
|
|
Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery, file e4233f15-c5e8-2860-e053-6605fe0a460a
|
1
|
|
Antithrombotic therapy in atrial fibrillation: state of the art and perspectives., file e4233f15-c68c-2860-e053-6605fe0a460a
|
1
|
|
Homocysteine induces VCAM-1 gene expression through NF-κB and NAD(P)H oxidase activation: Protective role of Mediterranean diet polyphenolic antioxidants, file e4233f15-d190-2860-e053-6605fe0a460a
|
1
|
|
Cardiovascular morbidity and mortality related to orthostatic hypotension: A meta-analysis of prospective observational studies, file e4233f16-4260-2860-e053-6605fe0a460a
|
1
|
|
Antiatherogenic effects of n-3 fatty acids - evidence and mechanisms, file e4233f16-6955-2860-e053-6605fe0a460a
|
1
|
|
ST segment/heart rate hysteresis improves the diagnostic accuracy of ECG stress test for coronary artery disease in patients with left ventricular hypertrophy, file e4233f17-6e14-2860-e053-6605fe0a460a
|
1
|
|
Lung ultrasonography: a practical guide for cardiologists, file e4233f17-6eea-2860-e053-6605fe0a460a
|
1
|
|
Scoring atherosclerosis in the search of evidence-based personalized medicine, file e4233f17-871e-2860-e053-6605fe0a460a
|
1
|
|
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial, file e4233f17-e12e-2860-e053-6605fe0a460a
|
1
|
|
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies, file e4233f17-e130-2860-e053-6605fe0a460a
|
1
|
|
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease, file e4233f17-e1d1-2860-e053-6605fe0a460a
|
1
|
|
Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and atrial thrombosis: An appraisal of current evidence, file e4233f17-e214-2860-e053-6605fe0a460a
|
1
|
|
Edoxaban for the Prevention of Thromboembolism in Patients with Atrial Fibrillation and Bioprosthetic Valves, file e4233f17-e453-2860-e053-6605fe0a460a
|
1
|
|
Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF, file e4233f17-e458-2860-e053-6605fe0a460a
|
1
|
|
Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry, file e4233f17-e464-2860-e053-6605fe0a460a
|
1
|
| Totale |
632 |